4,991 The Allstate Corporation $ALL Shares Bought by Orange Investment Advisors Inc.

Orange Investment Advisors Inc. grew its stake in The Allstate Corporation (NYSE:ALL) by 39.8% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 17,532 shares of the insurance provider’s stock after buying an additional 4,991 shares during the quarter. Orange Investment Advisors Inc.’s holdings in Allstate were worth $3,890,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Gables Capital Management Inc. purchased a new stake in Allstate during the second quarter worth $26,000. Kelleher Financial Advisors acquired a new stake in Allstate during the second quarter valued at $28,000. Evolution Wealth Management Inc. grew its position in Allstate by 7,000.0% during the first quarter. Evolution Wealth Management Inc. now owns 142 shares of the insurance provider’s stock valued at $29,000 after buying an additional 140 shares during the period. Allied Private Wealth LLC purchased a new position in Allstate in the second quarter valued at $29,000. Finally, Marshall & Sterling Wealth Advisors Inc. acquired a new position in shares of Allstate in the first quarter worth about $30,000. Hedge funds and other institutional investors own 76.47% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on ALL shares. Cantor Fitzgerald raised their target price on Allstate from $236.00 to $242.00 and gave the company a “neutral” rating in a research report on Thursday, July 9th. Morgan Stanley lowered their price target on Allstate from $265.00 to $240.00 and set an “equal weight” rating on the stock in a research report on Tuesday, October 6th. Zacks Research downgraded Allstate from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 15th. Jefferies Financial Group dropped their price objective on Allstate from $310.00 to $292.00 and set a “buy” rating on the stock in a report on Tuesday, October 6th. Finally, Raymond James Financial restated a “strong-buy” rating and issued a $315.00 price objective (up from $300.00) on shares of Allstate in a research report on Tuesday, August 11th. Two research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, Allstate has an average rating of “Hold” and a consensus price target of $270.19.

Key Headlines Impacting Allstate

Here are the key news stories impacting Allstate this week:

• Positive Sentiment: Allstate prevailed in a Texas coverage dispute involving a vacant property. The ruling supports the insurer’s ability to enforce policy vacancy provisions, potentially limiting claims costs and reinforcing underwriting discipline. Vacant clause can void cover: US court backs Allstate in Texas case
• Positive Sentiment: Allstate retained $9,000 in a subrogation-related dispute after a court placed the premature filing cost on the opposing liability carrier. The financial impact is small, but the decision may support Allstate’s claims-handling position. Allstate keeps $9,000 as premature subrogation cost falls on liability carrier
• Positive Sentiment: Bank of America raised its price target on Allstate to $340 from $336, signaling continued confidence in the insurer’s earnings outlook and valuation. BofA raises target from $336 to $340
• Positive Sentiment: A valuation-focused analysis said Allstate still appears inexpensive despite a 131% advance, potentially attracting investors who expect further benefits from strong insurance pricing and improved profitability. Allstate stock still looks cheap after its 131% run
• Neutral Sentiment: Allstate shares gained 3.76% in the referenced session, although KBW maintained its Sell rating, highlighting a disconnect between short-term trading momentum and analyst conviction. KBW keeps Sell rating
• Neutral Sentiment: UBS reiterated its Hold rating, offering no new catalyst but indicating the firm sees limited justification for changing its current view. UBS keeps Hold rating
• Negative Sentiment: Analysts expect Allstate’s third-quarter earnings per share to decline by double digits year over year, creating concern ahead of the company’s November earnings release. What to expect from Allstate’s next quarterly earnings report
• Negative Sentiment: KBW’s continued Sell rating remains a notable overhang, suggesting the firm believes Allstate’s strong rally has outpaced its fundamental value. KBW keeps Sell rating
• Negative Sentiment: The price target for Allstate’s preferred stock was reduced 12.29% to $19.21, signaling weaker expectations for that security, although it does not directly change the valuation of the common shares. Allstate preferred stock price target decreased

Insider Transactions at Allstate

In related news, COO Mario Rizzo sold 56,225 shares of the company’s stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $264.48, for a total transaction of $14,870,388.00. Following the completion of the sale, the chief operating officer owned 82,227 shares of the company’s stock, valued at approximately $21,747,396.96. This represents a 40.61% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider John E. Dugenske sold 32,996 shares of the company’s stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $269.33, for a total transaction of $8,886,812.68. Following the sale, the insider directly owned 13,054 shares of the company’s stock, valued at approximately $3,515,833.82. This represents a 71.65% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 1.55% of the stock is owned by corporate insiders.

Allstate Price Performance

Shares of Allstate stock opened at $253.24 on Monday. The business has a 50 day simple moving average of $245.78 and a two-hundred day simple moving average of $236.83. The Allstate Corporation has a 12 month low of $188.08 and a 12 month high of $277.22. The stock has a market capitalization of $64.03 billion, a P/E ratio of 5.06, a PEG ratio of 0.56 and a beta of 0.13. The company has a debt-to-equity ratio of 0.24, a current ratio of 0.36 and a quick ratio of 0.36.

Allstate (NYSE:ALL) last issued its quarterly earnings results on Wednesday, August 5th. The insurance provider reported $8.99 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.06 by $2.93. Allstate had a return on equity of 41.64% and a net margin of 18.97%. The firm had revenue of $18.60 billion for the quarter, compared to analyst estimates of $15.46 billion. During the same period in the previous year, the company posted $5.94 earnings per share. The business’s revenue was up 11.8% on a year-over-year basis. As a group, analysts predict that The Allstate Corporation will post 36.21 EPS for the current fiscal year.

Allstate Company Profile

Allstate Corp. (NYSE: ALL) is an insurance company that provides protection products and related services primarily in the United States. Its offerings include automobile, homeowners, renters, condominium, motorcycle and other personal property and casualty insurance, distributed through agents, brokers, direct channels and digital platforms.

The company also provides roadside assistance, identity-protection services and protection plans for consumer products. Through its acquisition of National General, Allstate expanded its presence in independent-agent distribution and specialty personal insurance.